| A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis (NCT07433335) | SciRhom GmbH | 2026-04-07 |
| A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight (NCT07525791) | Novo Nordisk A/S | 2026-04-07 |
| A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis. (NCT07523100) | Daishi Tian | 2026-04-07 |
| Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors (NCT07387068) | Genmab | 2026-04-07 |
| A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation (NCT07535112) | Bayer | 2026-04-07 |
| Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections (NCT06907199) | University of Texas Southwestern Medical Center | 2026-04-06 |
| HUMSCs Combined With Col I to Third-Degree Burn Wound (NCT07530003) | The First Affiliated Hospital of Xinxiang Medical College | 2026-04-06 |
| Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease (NCT07451613) | Leslie Thompson | 2026-04-06 |
| DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma (NCT07288112) | Diakonos Oncology Corporation | 2026-04-06 |
| The Primary Purpose of This Study is to Determine if Biotin, Vitamin B7 is an Effective Way to Label Platelets in Survival and Recovery Studies. (NCT07513532) | Bloodworks | 2026-04-06 |
| Exploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (NCT07447726) | Institute of Hematology & Blood Diseases Hospital, China | 2026-04-05 |
| A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants. (NCT07469085) | Shanghai Synvida Biotechnology Co.,Ltd. | 2026-04-04 |
| Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects (NCT07229716) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-04-04 |
| A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke (NCT07318714) | Astellas Pharma Inc | 2026-04-03 |
| CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy (NCT07016971) | Milton S. Hershey Medical Center | 2026-04-03 |
| A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor (NCT07243340) | ImmVira Pharma Co. Ltd | 2026-04-03 |
| A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male Adults (NCT07508228) | Pfizer | 2026-04-03 |
| Safety, PK and PD of FLQ-101 in Premature Neonates (NCT07093255) | FELIQS INC. | 2026-04-03 |
| A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations (NCT07288580) | Shanghai Euhearing Therapeutics Co., Ltd | 2026-04-02 |
| A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) (NCT07395258) | Boehringer Ingelheim | 2026-04-02 |
| A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions (NCT07421375) | Boryung Pharmaceutical Co., Ltd | 2026-04-02 |
| Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults (NCT07518589) | Shenzhen Kangzhe Biotechnology Co., Ltd. | 2026-04-02 |
| A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection (NCT07489482) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-02 |
| Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study (NCT07298408) | Florida A&M University | 2026-04-02 |
| Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH) (NCT07525466) | Beijing Tongren Hospital | 2026-04-01 |
| Safety and Tolerability Trial of Psilocybin in Healthy Older Adults (NCT07516405) | University of Colorado, Denver | 2026-04-01 |
| A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma (NCT07336472) | Fortvita Biologics (USA)Inc. | 2026-04-01 |
| Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy (NCT07258667) | University Hospital, Angers | 2026-04-01 |
| Personalized Antisense Oligonucleotide for A Single Participant With PACS1 Gene Mutation Associated With Schuurs-Hoeijmakers Syndrome (SHMS) (NCT07474298) | n-Lorem Foundation | 2026-04-01 |
| A Phase 1 Study of PVT401 in Healthy Subjects (NCT07423000) | Parvus Therapeutics, Inc. | 2026-04-01 |
| Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy (NCT07227285) | Cyllene Therapeutics | 2026-04-01 |
| A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors (NCT07509684) | Zhejiang Anglikang Pharmaceutical Co., Ltd. | 2026-04-01 |
| A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults (NCT07385248) | Addpharma Inc. | 2026-04-01 |
| Study of LUT017 Gel to Improve Healing of Skin Wounds After Removal of Benign Lesions in Healthy Adults (NCT07463378) | Antoni Ribas | 2026-04-01 |
| Encapsulated Probiotics & Gut Microbiota (NCT07439978) | University College Dublin | 2026-04-01 |
| Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. (NCT07526493) | Tongji Hospital | 2026-04-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232 (NCT07538466) | Addpharma Inc. | 2026-04-01 |
| NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer (NCT07595172) | West China Hospital | 2026-04-01 |
| A Study to Evaluate the Safety and Tolerability of Intravenous Stemis™ in Elderly Subjects With Mild to Moderate Frailty Syndrome (NCT07462819) | Ji Yan Biomedical Co., Ltd. | 2026-04-01 |
| Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion (NCT07446647) | Jose Cancelas | 2026-04-01 |
| Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects (NCT07540494) | GH Research Ireland Limited | 2026-04-01 |
| Study of IMC-S118AI in Type 1 Diabetes (NCT07493122) | Immunocore Ltd | 2026-04-01 |
| A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis (NCT07374471) | Mage Biologics | 2026-04-01 |
| A Study of HDM2020 in Patients With Advanced Sq-NSCLC (NCT07638891) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-04-01 |
| A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R (NCT07513649) | Dong-A ST Co., Ltd. | 2026-04-01 |
| Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents (NCT07092813) | Iterum Therapeutics, International Limited | 2026-04-01 |
| Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis* (NCT07339163) | Ohio State University | 2026-04-01 |
| Safety and Efficacy of Intrathecal NTF001 Injection in ALS (NCT07618585) | Ruijin Hospital | 2026-04-01 |
| A Phase 1 Study of Cizutamig in IgE Mediated Diseases (NCT07408869) | Candid Therapeutics | 2026-04-01 |
| Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma (NCT07335380) | NYU Langone Health | 2026-04-01 |
| Assess the Safety and Tolerability of SNS851 in Healthy Participants (NCT07417124) | Oneness Biotech Co., Ltd. | 2026-04-01 |
| Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients (NCT06490731) | New Valley University | 2026-04-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions (NCT07548957) | Korea United Pharm. Inc. | 2026-04-01 |
| Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer (NCT06818994) | Gustavo Vazquez | 2026-04-01 |
| Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML (NCT07026942) | Nationwide Children's Hospital | 2026-04-01 |
| Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo (NCT07519031) | Xijing Hospital | 2026-04-01 |
| A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus (NCT07538154) | Sinocelltech Ltd. | 2026-04-01 |
| ACT for Individuals With MNCD and Their Care Partners (NCT07239609) | Texas Tech University | 2026-04-01 |
| Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors (NCT07224568) | Seattle Children's Hospital | 2026-04-01 |
| Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer (NCT07075120) | University of Hawaii | 2026-04-01 |
| A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of RC010 Inhalation Powder in Healthy Participants (NCT07528703) | Nanjing Reju Therapeutics Co., Ltd | 2026-04-01 |
| First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics (NCT07516639) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2026-04-01 |
| Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma (NCT05842174) | VA Office of Research and Development | 2026-04-01 |
| First-In-Human Study of KHN922 for Injection (NCT07514975) | Chengdu Kanghong Biotech Co., Ltd. | 2026-04-01 |
| Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole (NCT07449390) | Acesion Pharma | 2026-04-01 |
| To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects (NCT07480824) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-04-01 |
| Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma (NCT07082270) | Roswell Park Cancer Institute | 2026-04-01 |
| A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers (NCT07544589) | Dispatch Biotherapeutics | 2026-04-01 |
| Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors (NCT07539610) | Institute of Hematology & Blood Diseases Hospital, China | 2026-04-01 |
| Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia (NCT07490327) | Moogene Medi Co., Ltd | 2026-04-01 |
| MB-CART2019.1 in Refractory Multiple Sclerosis (NCT07178431) | Miltenyi Biomedicine GmbH | 2026-04-01 |
| A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors (NCT07482319) | Beijing Geekgene Technology Co., LTD | 2026-04-01 |
| Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women (NCT07492706) | MAXVAX Biotechnology Limited Liability Company | 2026-04-01 |
| GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors. (NCT07407504) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-04-01 |
| GV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study (NCT07457281) | West China Hospital | 2026-04-01 |
| A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function (NCT07538973) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-04-01 |
| A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension (NCT06872112) | Joseph C. Wu | 2026-04-01 |
| Effect of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects (NCT07426042) | Min Kyu Park | 2026-04-01 |
| Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients (NCT07416383) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-01 |
| Precision Microbiota Interventions for Senoreduction Trial (NCT07462767) | Louisiana State University Health Sciences Center in New Orleans | 2026-04-01 |
| A Phase I Study Comparing the Safety, Pharmacokinetics and Renal Effects of VRP-034 and Marketed Polymyxin B in Healthy Volunteers (NCT07502144) | Venus Remedies Limited | 2026-04-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects (NCT07476157) | Addpharma Inc. | 2026-04-01 |
| A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients (NCT07185880) | Myosin Therapeutics Inc. | 2026-04-01 |
| Shockwave for Elbow and Wrist Spasticity in People With Spinal Cord Injury (NCT07501429) | Kessler Foundation | 2026-04-01 |
| Achilles Tendinopathy Embolization (NCT07477860) | Joint & Vascular Institute | 2026-04-01 |
| Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women (NCT07069582) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2026-04-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults (NCT07540910) | Enanta Pharmaceuticals, Inc | 2026-04-01 |
| Combining Latency Reversing Agents to Address the HIV Reservoir (NCT07384624) | Erasmus Medical Center | 2026-04-01 |
| Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients (NCT07247201) | Singapore General Hospital | 2026-04-01 |
| Phase Ib/II Study of Polatuzumab Vedotin in Combination With Rituximab and Chidamide in Newly Diagnosed Elderly Patients With Double-Expressor DLBCL (NCT07415980) | Sun Yat-sen University | 2026-04-01 |
| Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma (NCT07164560) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-01 |
| QLS5132 Combination Therapy in Advanced Solid Tumors (NCT07453394) | Qilu Pharmaceutical Co., Ltd. | 2026-04-01 |
| Empirical Radioactive Iodine Therapy in DTC (NCT07453225) | Assiut University | 2026-04-01 |
| NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies (NCT07563829) | NextPoint Therapeutics, Inc. | 2026-04-01 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017 Ophthalmic Ointment Following Single and Multiple Doses in Healthy Adult Participants (NCT07521748) | Nanjing Reju Therapeutics Co., Ltd | 2026-04-01 |
| Study on the Drug Interaction Between Buagafuran and Voriconazole (NCT07457203) | Beijing Union Pharmaceutical Factory Ltd | 2026-04-01 |
| Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP (NCT07599111) | Zhou Chengzhi | 2026-04-01 |
| A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together (NCT07446400) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2026-03-31 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Participants Via Single Intravenous Infusion (NCT07487545) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2026-03-31 |
| Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma. (NCT07320963) | Sun Yat-sen University | 2026-03-31 |